Rpb1 CTD (4H8) Mouse mAb and 3 more items

The University of Nebraska Medical Center (UNMC) has awarded a Purchase Order (PO) to Cell Signaling Technology Inc. of Boston, Massachusetts, for the procurement of four specialized antibody research reagents. The contract, numbered 4800157751, was issued on November 11, 2025, with a delivery date of November 17, 2025, and a total value of $1,477.00. The ordered items include: Phospho-Rpb1 CTD (Ser2) (E1Z3G), Rpb1 CTD (4H8) Mouse mAb, ETS-2 (D6L4J) Rabbit mAb, and Phospho-Rpb1 CTD (Ser5) (D9N5I) Rabbit mAb, each purchased in a quantity of one unit.

The contract is tax-exempt under number 05-8905401 and will be governed by the University of Nebraska's Standard Terms of Purchase. The shipping destination is set to UNMC Shipping and Receiving in Omaha, Nebraska, with the specific unloading point designated as DRC I 6058. The purchase order includes Net 30 payment terms, and the contact person for the order is Mohsin Raza. Each antibody reagent is priced between $336.00 and $401.00, reflecting the specialized nature of these research materials.